Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
Urology. 2013 May;81(5):1034-9. doi: 10.1016/j.urology.2013.01.007. Epub 2013 Mar 7.
To evaluate the efficacy of the AdVance transobturator male sling in the treatment of male stress urinary incontinence and to identify the preoperative predictors of a successful outcome.
All patients were considered for sling placement 1 year after radical prostatectomy or transurethral resection of the prostate. The degree of incontinence was assessed using the 24-hour pad weight test. A preoperative urodynamic assessment and cystoscopy were performed in all cases. Patients without sphincter contractions during the "repositioning test" were excluded. Since September 2010, we have implanted the AdVance XP transobturator sling. Cure was defined as no pad use.
From February 2008 to June 2011, 61 patients underwent transobturator sling (34 AdVance and 27 AdVance XP) insertion. In 26 cases, the sling was anchored with bioabsorbable sutures, and in 35 cases, it was not fixed. Of the 61 patients, 7 had a history of anastomotic stricture and 3 of radiotherapy. Preoperatively, median 24-hour pad weight was 200 g (range 25-1848). Finally, 26 patients had detrusor overactivity or low bladder compliance. The median follow-up was 26 months (range 12-53). The overall cure rate was 80% (49 of 61). Deterioration of continence was observed during follow-up in 2 patients. The preoperative variables (age, body mass index, 24-hour pad weight, International Consultation on Incontinence Questionnaire-Short Form, adverse urodynamics, sling fixation, AdVance XP) and their association with the surgical outcome were analyzed. The preoperative 24-hour pad weight correlated inversely with the outcome (odds ratio 0.996), with a 0.4% decrease in cure rate for each 1-g increase in the preoperative 24-hour pad weight. The complications included perineal hematoma in 2, acute urinary retention in 9, perineal numbness in 5, and de novo storage symptoms (urgency) in 5 patients.
The results of our study have shown that the AdVance and AdVance XP male slings are safe and efficient in patients with mild postprostatectomy stress incontinence. The severity of incontinence was the only predictor of a successful outcome.
评估 Advanc 经会阴男性吊带治疗男性压力性尿失禁的疗效,并确定手术成功的术前预测因素。
所有患者均在根治性前列腺切除术或经尿道前列腺切除术 1 年后考虑吊带置入。使用 24 小时尿垫重量试验评估失禁程度。所有病例均进行术前尿动力学评估和膀胱镜检查。在“重新定位试验”中没有括约肌收缩的患者被排除在外。自 2010 年 9 月以来,我们已经植入了 Advanc XP 经会阴吊带。治愈定义为不使用尿垫。
2008 年 2 月至 2011 年 6 月,61 例患者接受经会阴吊带(34 例 Advanc 和 27 例 Advance XP)置入。26 例吊带采用可吸收缝线固定,35 例未固定。61 例患者中,7 例有吻合口狭窄史,3 例有放疗史。术前中位 24 小时尿垫重量为 200g(范围 25-1848g)。最终,26 例患者存在逼尿肌过度活动或低膀胱顺应性。中位随访时间为 26 个月(范围 12-53 个月)。总体治愈率为 80%(61 例中的 49 例)。2 例患者在随访期间出现尿失禁恶化。分析了术前变量(年龄、体重指数、24 小时尿垫重量、国际尿失禁咨询问卷-短表、不良尿动力学、吊带固定、Advance XP)及其与手术结果的关系。术前 24 小时尿垫重量与手术结果呈负相关(优势比 0.996),术前 24 小时尿垫重量每增加 1g,治愈率降低 0.4%。并发症包括会阴血肿 2 例,急性尿潴留 9 例,会阴麻木 5 例,新发储尿症状(尿急)5 例。
我们的研究结果表明,Advanc 和 Advance XP 男性吊带在轻度前列腺切除术后压力性尿失禁患者中安全有效。尿失禁的严重程度是手术成功的唯一预测因素。